INFLUENCE OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND HEART DYSSYNCHRONY ON THE COURSE OF ARTERIAL HYPERTENSION

V Kapustnik1, I Kostuyk1, B Shelest1

  • 1Kharkiv National Medical University, Ukraine.

Georgian Medical News
|September 12, 2018
PubMed

Insights

Left ventricular dysfunction and heart dyssynchrony predict worsening arterial hypertension, diabetes mellitus type 2, and obesity. Early detection of these cardiac issues is crucial for managing disease progression and improving patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Hypertension Research

Background:

  • Arterial hypertension, diabetes mellitus type 2 (DM2T), and obesity are significant comorbidities.
  • Left ventricular (LV) dysfunction and heart dyssynchrony are implicated in cardiovascular disease progression.
  • Understanding their role in this patient population is crucial for prognosis.

Purpose of the Study:

  • To determine the role of left ventricular dysfunction and heart dyssynchrony in the disease course and prognosis of patients with arterial hypertension, DM2T, and obesity.
  • To identify specific echocardiographic parameters indicative of disease progression.

Main Methods:

  • Retrospective analysis of clinical and echocardiographic data from 135 patients.
  • Assessment of LV diastolic function using Doppler transmitral diastolic flow.
  • Evaluation of heart dyssynchrony using M-mode and Doppler (PW/CW).
  • Categorization into groups based on disease worsening (exaggerated target-organ damage) over 6 months.

Main Results:

  • LV diastolic dysfunction is significantly associated with hypertension progression.
  • Abnormal early (E) and late (A) ventricular filling velocities, and a reduced E/A ratio (≤1.0) were more frequent in patients with disease progression.
  • Decreased diastolic filling time (≤200 ms) and prolonged isovolumic relaxation time (IVRT ≥201 ms) were also significantly associated with disease progression.
  • LV dyssynchrony, particularly when associated with LV hypertrophy, is a strong predictor of a worsening disease course.

Conclusions:

  • Diastolic dysfunction is a significant factor in hypertension progression among patients with T2DM and obesity.
  • LV dyssynchrony is a valuable predictor of worsening disease course in hypertensive patients with T2DM and obesity.
  • Echocardiographic assessment of LV diastolic function and dyssynchrony can aid in risk stratification and management.

Related Concept Videos

Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.9K
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
6.7K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
613
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
736
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
471
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
509